FILING ANALYSIS · TUESDAY, OCTOBER 27
CHEMED CORP CHE — 8-K: Results of Operations and Financial Condition
positive
Chemed Corporation reported a 10.6% increase in revenue to $690.9 million and a 22.2% increase in GAAP Diluted EPS to $5.45, driven by strong performance in its VITAS segment, which saw a 12.2% increase in net patient revenue and a 44.7% increase in net income, excluding certain discrete items.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →